RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

• Protocol code: ALXN1210-CSA-AKI-318
• EudraCT code: No aplica
• Research group: Shock, Organ Dysfunction and Resuscitation
• Service: RTA ICU
• Principal investigator:  Ferrer Roca, Ricard
• Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
• Phase: Fase III